The independent clinical utility of assessing for ATRX status by immunohistochemistry in adults is unclear, especially considering that sequencing and/or methylation profiling would typically be required to confirm less common tumor diagnoses in the IDH-wt setting that may harbor ARTX alterations. Here, IDH1 is linked to neoplasm.